Orange Book product · Generic (ANDA)
COLCHICINE
COLCHICINE
At a glance
Apr 29, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 29, 2024
2 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
COLCHICINE
Strength
0.6MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 210757
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of COLCHICINE
- 2023LODOCOBrand (NDA)
NDA 215727 · AGEPHA PHARMA FZ
- 2019GLOPERBABrand (NDA)
NDA 210942 · SCILEX PHARMS
- 2014MITIGAREBrand (NDA)
NDA 204820 · HIKMA INTL PHARMS
- 2009COLCRYSBrand (NDA)
NDA 022352 · TAKEDA PHARMS USA
- 2026COLCHICINEGeneric (ANDA)
ANDA 212880 · MICRO LABS
- 2026COLCHICINEGeneric (ANDA)
ANDA 210633 · MACLEODS PHARMS LTD
- 2024COLCHICINEGeneric (ANDA)
ANDA 217620 · ANNORA PHARMA
- 2024COLCHICINEGeneric (ANDA)
ANDA 215463 · AUROBINDO PHARMA LTD
- 2022COLCHICINEGeneric (ANDA)
ANDA 209173 · STRIDES PHARMA
- 2022COLCHICINEGeneric (ANDA)
ANDA 215444 · AUROBINDO PHARMA LTD
- 2021COLCHICINEGeneric (ANDA)
ANDA 208993 · HETERO LABS LTD V
- 2021COLCHICINEGeneric (ANDA)
ANDA 203976 · PH HEALTH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
